First Quadrant’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,212
Closed -$307K 612
2020
Q4
$307K Buy
+3,212
New +$331K 0.03% 306
2019
Q4
Sell
-574
Closed -$34K 614
2019
Q3
$34K Buy
+574
New +$36.6K ﹤0.01% 547

Other funds holding TNDM

First Quadrant's TNDM Position: Q1 2021 in Review

First Quadrant sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 3,212 shares — an estimated $307K sold.

First Quadrant first reported a position in TNDM in Q3 2019 and held it in 2 quarters. The position peaked at $307K in Q4 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • First Quadrant reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • First Quadrant sold 3,212 Tandem Diabetes Care shares in Q1 2021, an estimated $307K.
  • First Quadrant first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 2 quarters.
  • First Quadrant's Tandem Diabetes Care position peaked at $307K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.